patent posts

Feed

Garmin Slumps After Patent Defeat

Garmin (GRMN)Thursday morning, GPS specialist Garmin Ltd. (GRMN) said it lost a patent dispute with Japanese firm Pioneer Corp. The District Court of Dusseldorf in Germany found that two patents owned by Pioneer were infringed by a certain functionality in Garmin's software.

However, Garmin says it has already worked out "minor software revisions that eliminate the narrow functionality at issue in the litigation." As a result, the company doesn't expect any significant impact on its ability to import and sell its navigational products.

Continue reading Garmin Slumps After Patent Defeat

Apple Receives Text Filter Patent

It took two years, but a patent for a communication control application has at last been approved for Apple Inc. (AAPL). The newly patented application allows for parents, or anyone else, to disallow "unauthorized" text messages to be sent from a protected device.

Continue reading Apple Receives Text Filter Patent

Rambus Licenses Patents to NVIDIA

Rambus (RMBS)Rambus (RMBS - option chain) shares are rising today after the company announced it has signed a patent licensing agreement with NVIDIA Corp. (NVDA), under which RMBS grants NVDA a patent license for certain memory controllers at a 1% royalty rate for SDR memory controllers and a 2% royalty rate for other memory controllers. However, neither company has signed a release of liability or dismissed any litigation between them. RMBS had earlier charged that NVDA has infringed on some of its chip patents. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on RMBS.

Continue reading Rambus Licenses Patents to NVIDIA

Sanofi-Aventis Dips on Eloxatin Patent Settlements

SNY logoSanofi-Aventis (SNY - option chain) stock is trading lower today after the company announced this morning that it has settled patent infringement suits with Hospira (HSP) and Par Pharmaceutical Companies (PRX) related to certain generic versions of its cancer treatment Eloxatin. The settlements will stop HSP and PRX from selling generic versions of Eloxatin from late-June until August 2012. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on SNY.

This morning, SNY opened at $36.51. So far today the stock has hit a high of $36.69 and a low of $36.43. As of 12:10, SNY is trading at $36.69, down $0.51 (-1.4%). The chart for SNY looks neutral and S&P gives SNY a neutral 3 STARS (out of 5) hold ranking.

Continue reading Sanofi-Aventis Dips on Eloxatin Patent Settlements

Myriad Genetics Drops on Patent Ruling

MYGN logoMyriad Genetics (MYGN) stock is trading lower today after a Federal District Court ruled that the company's claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis are invalid. The company said it will appeal the decision. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on MYGN.

This morning, MYGN opened at $23.86. So far today the stock has hit a high of $24.00 and a low of $23.07. As of 11:55, MYGN is trading at $23.63, down $1.27 (-5.1%). The chart for MYGN looks bullish.

Continue reading Myriad Genetics Drops on Patent Ruling

Vical soars after winning U.S. patent for flu vaccines

Vical Inc. (NASDAQ: VICL) surged higher out of the gate Thursday after scoring a U.S. patent for its pandemic and seasonal influenza vaccines, including those to shield against H1N1 (swine flu) and H5N1 (avian flu). Both treatments use Vical's patented Vaxfectin adjuvant, which helps to boost immunity.

While the H5N1 vaccine has completed early-stage human trials, the H1N1 vaccine has yet to be tested on human subjects. Positive results have been recorded from tests conducted on mice and rabbits, but VICL said earlier this year that it will require more funding to begin large-scale trials on humans.

Continue reading Vical soars after winning U.S. patent for flu vaccines

Microsoft fined $290 million in a patent ruling

A judge in Texas has ordered Microsoft (MSFT) to stop selling some versions of its Word software in the United States within two months. This follows a May decision that found Word infringes on a Canadian tech firm's patent.

The offending programs are Word 2003 and Word 2007, which seem to have borrowed technology on how to encode and display information. In addition, MSFT was ordered to pay $290 million to the Canadian firm i4i for damages and interest. The judge also issued an injunction that will take effect in 60 days, this move will not allow MSFT to sell Word products including the patented technology.

Continue reading Microsoft fined $290 million in a patent ruling

Reynold's American (RAI) wins patent dispute

RAI logoReynolds American (NYSE: RAI - option chain) shares are rising today after a federal jury ruled that the company did not infringe upon Star Scientific Inc.'s (NASDAQ: STSI) patents regarding a method to reduce cancer-causing toxins in tobacco. The jury determined the two STSI patents at issue were not valid. STSI is expected to file an appeal. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on RAI.

RAI opened this morning at $37.03. So far today the stock has hit a low of $36.86 and a high of $37.97. As of 12:20, RAI is trading at $37.29 up.96 cents(2.6%). The chart for RAI looks neutral and S&P gives RAI a neutral 3 STARS (out of 5) hold ranking.

Continue reading Reynold's American (RAI) wins patent dispute

InterDigital (IDCC) resolves Samsung patent dispute

IDCC logoInterDigital (NASDAQ: IDCC - option chain) shares opened higher today after the company announced it has resolved its patent dispute with Samsung Electronics Co. Under the agreement, IDCC has granted Samsung a license that covers 3G wireless handsets through 2012. The license allows IDCC to collect royalties from Samsung. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on IDCC.

IDCC opened this morning at $28.10. So far today the stock has hit a low of $25.35 and a high of $28.98. As of 12:35, IDCC is trading at $28.98, up 0.29 (1.1%). The chart for IDCC looks neutral.

For a bullish hedged play on this stock, I would consider a January bull-put credit spread below the $15 range.

Continue reading InterDigital (IDCC) resolves Samsung patent dispute

Business method, software patents limited: Big (bad?) news for tech firms

I've long thought the "business method patent" to be one of the biggest shams involved, and I am neither alone in this opinion or innocent of involvement in the scheme. Essentially, business method patents protect the manner of doing something; for instance, you might be able to patent your unique way of sorting envelopes. "I start by separating the colored envelopes from the white ones, and then sort by size," you might say. "Then I alphabetize each stack according to addressee first name."

As of yesterday, your patent would be denied. The Court of Appeals for the Federal Circuit handed down a ruling in the Ex Parte Bilski case that would severely limit software and business process patents, essentially requiring that these patents only be approved if the patent in question (1) is tied to a particular machine or apparatus, or (2) transforms a particular article into a different state or thing.

If this is upheld by the Supreme Court (which I tend to believe it would be), this will have far-reaching ramifications for technology companies like Amazon (NASDAQ: AMZN), which have protected a simple process (the One-Click ordering system) that is only an idea, not a machine. I've always found the concept that ideas could be patented to be noisome; taking the One-Click as an example, it is certainly not an idea that only one individual could ever conceive, and it's stifling to keep other competitors from using it. In my opinion, competition should exist based on the excellence of products and services and the development of brand identity, not on legal protectionism. Jeffrey Bezos may not agree ...

Qualcomm's (QCOM) case keeps getting worse

Qualcomm (NASDAQ: QCOM) lost a patent ruling against rival Broadcom (NASDAQ: BRCM). That was some time ago. It prevents Qualcomm from selling certain chips in the US. That hurts its profits and makes its handset partners very unhappy.

Things got worse for the wireless chip company. An appeals court turned down its request to temporarily start selling the chips again. According to The Wall Street Journal, "The U.S. Court of Appeals for the Federal Circuit, without providing details, ruled Tuesday that Qualcomm had not met its burden of proof to win a stay pending appeal of the injunction."

Qualcomm's bad patent habits have it in court cases against its largest customer, Nokia (NYSE: NOK), as well as Broadcom. That creates a nightmare for shareholders.

Although handset sales may be slowing a bit. Qualcomm has a wonderful business providing chips and software to the industry. That franchise took its stock from $15 less than five years ago to $53 in mid-2006. Disputes with customers and rivals have helped push that share price down to under $38.

With the new court ruling,Qualcom's share price is likely to stay down a lot longer.

Douglas A. McIntyre is an editor at 247wallst.com.

eBay and MercExchange settle long-term feud

eBay headquartersIn what may end up being a net positive for eBay, albeit possibly an expensive one, a settlement has been reached in the litigation over patent infringement between eBay Inc. (NASDAQ: EBAY) and MercExchange. Financial figures of the settlement have not been disclosed, but a report from Computerworld indicates that eBay shall purchase the three patents which were the subject of the litigation, as well as a number of other related technologies and developments.

Mike Jacobson, eBay senior vice president and general counsel, was quoted by Computerworld as stating: "In addition to resolving the litigation, this settlement gives us access to additional intellectual property that will help improve and further secure our marketplaces." MercExchange founder and CEO Thomas Woolston, is quoted in the same report as stating: "It seemed like the right time to put it behind us."

In May of 2003, a jury in the case found eBay guilty of patent infringement and an injunction was sought and granted. However, in reviewing the US Court of Appeals decision, the Supreme Court unanimously derailed the long standing practice of issuing immediate injunctions in cases of intellectual property infringement, insisting that in the future, such injunctions must meet the requirements of a four-factor test.

Crocs (CROX) finds trouble with EU patent

CROX logoCrocs Inc. (NASDAQ: CROX) shares are plummeting again this morning after news came out on Friday that the company's attempt to patent its uniquely-styled shoes in Europe may be unsuccessful. The European Union's Office for Harmonization in the International Market ruled in December that CROX's Beach model shoes "lack individual character" compared with other similar brands, according to a Forbes.com article published Friday evening. The ruling struck a blow, as CROX now faces more difficulty in pushing out its competitors in Europe. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on CROX.

After hitting a one-year low of $21.675 in March, the stock hit a one-year high of $75.21 in October. This morning, CROX opened at $32.76. So far today the stock has hit a low of $27.64 and a high of $32.96. As of 10:50, CROX is trading at $28.41, down $4.34 (-13.2%). The chart for CROX looks bearish and steady.

For a bearish hedged play on this stock, I would consider a March bear-call credit spread above the $45 range. A bear-call credit spread is an options position that combines the purchase and sale of call options to hedge risk in case the stock doesn't do what you think but still leverage nice returns. For this particular trade, we will make a 7.5% return in 11 weeks as long as CROX is below $45 at March expiration. Crocs would have to rise by more than 56% before we would start to lose money.

Continue reading Crocs (CROX) finds trouble with EU patent

Qualcomm (QCOM) unfazed by court ruling

QCOM logoQUALCOMM Inc. (NASDAQ: QCOM) stock opened lower this morning after a federal judge in California ruled on Monday that the company must immediately halt selling third-generation (3G) WCDMA cellular chips, as they seem to infringe on patents held by rival Broadcom (NASDAQ: BRCM). According to analysts, QCOM may eventually have to pay royalties to BRCM due to the ruling, which would negatively affect its guidance, though the ruling allows QCOM time to implement a workaround solutions before any royalties can be imposed. Shortly after the open, QCOM announced the launch of new chips it says will comply with the ruling. If you think this stock won't be rising too far in the coming months, then now could be a good time to look at a bearish hedged play on QCOM, since options prices could be high at this time.

After hitting a one-year high of $47.72 in May, the stock hit a one-year low of $35.23 in August. This morning, QCOM opened at $38.23. So far today the stock has hit a low of $38.12 and a high of $39.80. As of 11:15, QCOM is trading at $38.92, down $0.42 (-1.1%). The chart for QCOM looks bearish and steady, while S&P gives the stock a neutral 3 STARS (out of 5) hold rating.

Continue reading Qualcomm (QCOM) unfazed by court ruling

Apple and AT&T sued over iPhone's 'Visual Voicemail' feature

One of the hottest names in tech, Apple, Inc. (NASDAQ: AAPL), and its wireless partner AT&T, Inc. (NYSE: T), have been sued by Klausner Technologies Inc. for patent violation. Although patent litigation is far and away the joke of the law business these days, this one involves the "Visual Voicemail" feature found on the iPhone, which lets customers visually see their voicemails and go directly to any of them (instead of the standard chronological order most wireless carriers offer).

Kluasner Technologies claims that two of its patents are being violated by Apple and AT&T, and that it is entitled to $360 million in total damages, including future royalties from both companies based on continued usage of the visual voicemail feature by iPhone customers.

From the actions by Klausner Technologies this week, it seems that the company is a patent litigation hound more than anything. The company also filed suits against eBay Inc. (NASDAQ: EBAY)'s Skype unit, Comcast Corp. (NYSE: CMCSA) and more for violation of Klausner's VoIP (Voice over Internet Protocol) patents. It wants an additional $300 million in those lawsuits. Klausner settled with more companies last year over its VoIP patents and this year it looks to be continuing the trend.

Next Page >

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 11, 2012: 02:45 AM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1328946302995 ms.